Insmed reported $48.57M in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
DBV Technologies DBVT:US 11.42M 13K
Acelrx Pharmaceuticals ACRX:US $ 2.72M 594K
Alimera Sciences ALIM:US $ 6.6M 2.1M
Cytokinetics CYTK:US $ 19.84M 1.25M
Dynavax Technologies DVAX:US $ 20.19M 17.59M
Gilead Sciences GILD:US $ 583M 122M
Heron Therapeutics HRTX:US $ 8.23M 4.42M
Insmed INSM:US $ 48.57M 12.79M
Mirati Therapeutics MRTX:US $ 27.94M 7.22M
Novartis NVS:US $ 5083M 470M
Regeneron Pharmaceuticals REGN:US $ 470.3M 93.7M
Sarepta Therapeutics SRPT:US $ 54.01M 22.73M
Seattle Genetics SGEN:US $ 87.23M 27.6M
Ultragenyx Pharmaceutical RARE:US $ 23.68M 6.55M
Vertex Pharmaceuticals VRTX:US $ 173.6M 21.4M